Work

Improving the Efficiency of the Development of Drugs for Stroke

Year: 2012
Type: article
Abstract: The mortality and morbidity associated with stroke makes the development of new drugs a research priority. Recent unsuccessful clinical trials have reduced enthusiasm for the development of neuroprotective drugs. Here, we use empirical evidence derived from systematic reviews of stroke drug development to identify stages of drug development which might be improved. We then propose exemplar strategies which may be helpful, along with some basic economic modelling of what the impact of such strategies might be. This suggests that relatively straightforward measures might reduce the costs of drug development by $5·8 bn or 31%.
Language: English
Open Access status: green
OpenAlex ID: W2100844690
FWCI: 11.95
Cites: 22
Cited by: 62
Related to: 10